Unknown

Dataset Information

0

Structure-Based Virtual Screening for the Discovery of Novel Inhibitors of New Delhi Metallo-?-lactamase-1.


ABSTRACT: Bacterial resistance has become a worldwide concern after the emergence of metallo-?-lactamases (MBLs). They represent one of the major mechanisms of bacterial resistance against beta-lactam antibiotics. Among MBLs, New Delhi metallo-?-lactamase-1 NDM-1, the most prevalent type, is extremely efficient in inactivating nearly all-available antibiotics including last resort carbapenems. No inhibitors for NDM-1 are currently available in therapy, making the spread of NDM-1 producing bacterial strains a serious menace. With this perspective, we performed a structure-based in silico screening of a commercially available library using FLAPdock and identified several, non-?-lactam derivatives as promising candidates active against NDM-1. The binding affinities of the highest scoring hits were measured in vitro revealing, for some of them, low micromolar affinity toward NDM-1. For the best inhibitors, efficacy against resistant bacterial strains overexpressing NDM-1 was validated, confirming their favorable synergistic effect in combination with the carbapenem Meropenem.

SUBMITTER: Spyrakis F 

PROVIDER: S-EPMC5767890 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structure-Based Virtual Screening for the Discovery of Novel Inhibitors of New Delhi Metallo-β-lactamase-1.

Spyrakis Francesca F   Celenza Giuseppe G   Marcoccia Francesca F   Santucci Matteo M   Cross Simon S   Bellio Pierangelo P   Cendron Laura L   Perilli Mariagrazia M   Tondi Donatella D  

ACS medicinal chemistry letters 20171126 1


Bacterial resistance has become a worldwide concern after the emergence of metallo-β-lactamases (MBLs). They represent one of the major mechanisms of bacterial resistance against beta-lactam antibiotics. Among MBLs, New Delhi metallo-β-lactamase-1 NDM-1, the most prevalent type, is extremely efficient in inactivating nearly all-available antibiotics including last resort carbapenems. No inhibitors for NDM-1 are currently available in therapy, making the spread of NDM-1 producing bacterial strain  ...[more]

Similar Datasets

| S-EPMC4348537 | biostudies-literature
| S-EPMC7279046 | biostudies-literature
| S-EPMC3212353 | biostudies-literature
| S-EPMC3652859 | biostudies-literature
| S-EPMC8000195 | biostudies-literature
| S-EPMC5599375 | biostudies-literature
| S-EPMC7841178 | biostudies-literature
| S-EPMC6527342 | biostudies-literature
| S-EPMC5441612 | biostudies-literature
| S-EPMC3204651 | biostudies-literature